David Mattingly, MD
Adult Reconstructive Orthopaedic Surgery · Chestnut Hill, MANPI 1558328443
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $196,366 of the $198,376 with a category attached, or 99.0%. Depuy Synthes Products, Inc. accounts for 99.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $47,348 and has fallen 99.6% since, to $172 in 2025.
Across 45 payments — averaging $4408.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$196K
- Medical Device Business Services, Inc.$1K
- Stryker$606
- Zimmer Biomet$113
- Johnson & Johnson$97
- Pacira Therapeutics, Inc.$47
- plus $120 from 5 others
Across 19 payments — averaging $841.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$16K
What the payments were for
- Royalty or licence$196,36699%
- Travel & lodging$9000%
- Food & beverage$1,1101%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 18 | $196,366 |
| Medical Device Business Services, Inc. | 7 | $1,027 |
| Stryker | 6 | $606 |
| Zimmer Biomet | 1 | $113 |
| Johnson & Johnson(2 entities) | 5 | $97 |
| Pacira Therapeutics, Inc. | 2 | $47 |
| Baudax Bio Inc. | 2 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Convatec Inc. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$198,376 in reported general payments places this provider in the 80th percentile of 24 adult reconstructive orthopaedic surgery providers in Massachusetts.
See all adult reconstructive orthopaedic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 13 | $126 |
| Amoxicillin | 26 | $59 |
| Meloxicam | 31 | $45 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Chestnut Hill
- James BonoBoston$6.3M
- Michael MasonBrighton$1.5M
- Vivek ShahBoston$1.4M
- Eric SmithBoston$649K
- David FehnelPeabody$149K
- Jay PatelFall River$52K
- Richard IorioBurlington$29K
- Hayden BoxBoston$17K
- Aman SharmaPlymouth$11K
- Peter WhiteBoston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.